AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX): Trading Secrets for Today’s Investors

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) dropped at the rate of -1.59% in the last day from $3.15 to $3.10 The stock price went upward in 5 of the last 10 days and has generated 47.62% during the last two weeks. There was a decrease in both volume and price. This is usually interpreted as a good sign as traders widely believe falling stock should see declining volume. In the last day the trading volume dropped at the rate of -7.85 million shares and in total 3.14 M shares exchanged hands for about $9.75 million.

Inside ACRX’s Recent Trend

AcelRx Pharmaceuticals, Inc. (ACRX) lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break down through the support point at $3.14 will initially suggest a lower tendency for declines in the price and this might very well be an early sign that a trend shift is coming. Short-term traders are anticipated to see a retreat of -11.37% over the course of a quarter and, with 90% chance the price will be floating in the range of $1.74 and $2.78 in this timeframe.

AcelRx Pharmaceuticals, Inc. Technical Signals

ACRX has witnessed its long term and short term MA triggering a buy signal. Many traders watch for short-term averages to cross above long-term averages to signal the beginning of a uptrend. Upon corrections, the price will meet support from the averages between $2.50 and $2.35. A break down through these support points will trigger sell signals. Some other technical concerns emerged as well, putting in risk the future growth of the stock in the next couple of days. Its pivot point high generated sell signal on Monday July 17, 2017, which calls for additional declines until the stock forms a new pivot point low, as this could be a buying opportunity. The downbeat movement of both volume and price during the recent session is interpreted as a good sign because traders usually believe falling stock should see declining volume.

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Support And Resistance Levels

In case of pullback, the next support the price will capture from accumulated volume will not be far away from current price at $2.65 and $2.50. In case of gains, the next resistance from accumulated volume will not be far away from today’s level at $3.15.

It is important to note, however, that the stock needs to make its way through natural risk while testing a key support level. Once this support is broken, another support level will be to be established at a lower level. Turning back to this stock, AcelRx Pharmaceuticals approaches the first support point just current price at $2.65. In case of a break, the next support we will see from accumulated volume is going to be at $2.50 and $2.40. Accumulated volume is going to prevent the price from rising further at $3.15 and this action will lead the price to take a temporary pause or stay muted for a few days.

AcelRx Pharmaceuticals, Inc. (ACRX) Risk Assessment

A volatility based measure Bollinger Bands suggests this stock poses high risk. In the most recent session, the stock price hovered around $0.15 between high and low, or 4.92%. The average volatility for the past week stood at 9.84%.

The stock is in overbought condition based on RSI(14) readings and sits at the top end of the trend. In general, this will advocate a great exit point for short term investors, but in some cases it takes more time for the trend to shift while the stock is being overbought and the Relative Strength Index keeps going higher. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. The stock correction is due. The decline may accelerate to the downside in the near term but it is reasonable to consider what the key support levels may be that would support a bounce back to the upside for stock.


Previous ArticleNext Article

Related Post

The Walt Disney Company (DIS) and U.S. Bancorp (US... The Walt Disney Company (NYSE:DIS) shares are down more than -5.42% this year and recently increased 1.71% or $1.71 to settle at $101.68. U.S. Bancorp...
Reviewing the Insider Trends for Yamana Gold Inc. ... Recent insider trends for Yamana Gold Inc. (NYSE:AUY) have caught the attention of investors. Insider data is useful because it can reveal what a comp...
Reviewing the Insider Trends for Synchrony Financi... Recent insider trends for Synchrony Financial (NYSE:SYF) have caught the attention of investors. Insider data is useful because it can reveal what a c...
The Fundamental Case for and Against Automatic Dat... Automatic Data Processing, Inc. (NASDAQ:ADP) trade is getting exciting but lets take a deeper look whether it is as good a moment. Now trading with a ...
Dissecting the Insider Trading Patterns of Nevro C... Recent insider trends for Nevro Corp. (NYSE:NVRO) have caught the attention of investors. Insider data is useful because it can reveal what a company’...

Leave a Reply

Your email address will not be published.